New Trial Upheld For J&J After $417M Talc Verdict

Law360 (July 10, 2019, 8:26 PM EDT) -- A California appeals court on Tuesday upheld a lower court's decision to grant Johnson & Johnson a new trial after an initial $417 million jury award that was later tossed in a suit alleging that the company’s talcum baby powder caused a woman's fatal ovarian cancer.

A three-judge Second District Court of Appeal panel said that the evidence over whether talc caused Eva Echeverria's cancer was in "significant conflict" and that a reasonable jury could have concluded that the evidence didn't sufficiently establish that talc was a substantial factor in causing her cancer. The panel also found that there was sufficient evidence that...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS